Green Manufacturing of Cephalosporin Antibiotics Using Recombinant Deacetylase

 

Introduction

 

Developing a cost-effective technology for the green manufacturing of antibiotics using a proprietary enzyme. Anovel enzyme will be developed using recombinant DNAtechnology.

 

State of Development

 

Pre-Commercialization

 

Unique Features of the Product/Technology

 

Lower energy requirements and environmental footprint. It has got higher productivity.

 

Market Potential

 

The green chemistry represents a market opportunity that will grow from $2.8 billion in 2011 to $98.5 billion by 2020. The global sales of drugs that could potentially use the proposed product for manufacturing is valued around $1.3 billion in 2012.

 

For further information please contact :  

 

Biotechnology Industry Research Assistance Council (BIRAC)
1st Floor ,MTNL Building ,9 ,
CGO Complex, Lodhi Road,
New Delhi-110003
E-mail: birac.dbt@nic.in
Phone: + 91-11-24389600